2020 Rosenthal Center Cannabis Perceptions Poll
Dr. Mitch Rosenthal on the Perspectives of Marijuana Legalization in the Democratic Primary
Dr. Mitch Rosenthal on Politicians' Lack of Attention to the Opioid Crisis
Dr. Mitch Rosenthal on the Realities of the Opioid Crisis
Click here for video
Dr. Mitch Rosenthal on the Trump Administration Backpedaling on Vaping
Dr. Mitch Rosenthal on the FDA's Lackluster Response to the Vaping Crisis
Click here for video.
Dr. Mitch Rosenthal on the Lack of Progress in Combatting the Opioid Crisis
Dr. Mitch Rosenthal on the Need for $100 Billion to Combat Addiction and Support Recovery
Dr. Mitch Rosenthal on the Need for National Laws That Prevent Vaping
Dr. Mitchell Rosenthal on President Trump's Decision to Back Away from a Flavored E Cigarette Ban
Dr. Mitch Rosenthal Proposes Changes to Safe Injection Sites
Dr. Mitch Rosenthal on the Need to Support a FDA Ban on Flavored E Cigarettes
Dr Mitch Rosenthal on the Need to Ban Vaping Across the Entire Country
Dr. Mitchell Rosenthal on Upcoming Opioid Litigation Cases this Month
Dr. Mitchell Rosenthal on the Need to Stop Vaping Nationally
Dr. Mitch Rosenthal on the Need to Follow Massachusetts' Lead on Banning All Vaping Products
Dr. Mitch Rosenthal on the Dangers and Risks Associated with Vaping
Dr. Mitch Rosenthal on the Dangers of Vaping
Dr. Mitch Rosenthal on the Federal Government's Move to Ban Flavored E Cigarettes
Dr. Mitch Rosenthal on the Dangers of New & Powerful Marijuana that is Available
Dr. Mitch Rosenthal on the Need for Any Opioid Crisis Settlement to Focus on Treatment
Dr. Mitch Rosenthal on the Risks of Overprescribing Opioids to Children for Tonsillectomy
Dr. Mitch Rosenthal on the Lack of Attention to the Opioid Crisis in the Current Political Discussion
Dr Mitch Rosenthal on the Need for Comprehensive Action Plans to Combat the Opioid Crisis
Dr Mitch Rosenthal on the Susceptibility of the Adolescent Brain to Drugs and Addiction
Dr Mitch Rosenthal on the Overprescription of Opioid Medication in the United States
Dr. Mitch Rosenthal on the Need to Emulate Effective Overdose Prevention Programs from Dayton, Ohio
New Opioid Taxes & Employer-based Solutions to the Opioid Epidemic
Dr. Mitch Rosenthal's Good Day NY Addiction and Best Treatment Practices Segment
President Trump Lacks Opioid Crisis Strategy
Gottlieb's Disappointing Departure from FDA
Reckless Pursuit of Marijuana Legalization and Commercialization
We Need Treatment Funding, Not a Border Wall, to Solve Drug Crisis
VIDEO on Alex Berenson's Book, Tell Your Children
It's Time to Rethink Our National Drug Policy
Dayton's Successful Strategies to Address Opioids
President Trump: don’t gut the budget of the White House Office of National Drug Control Policy!
Slashing spending to just $24 million from $388 million will harm nation-wide efforts to fight the deadly opioid epidemic.
ONDCP oversees essential drug programs and integrates critical government resources. Don’t be penny wise and pound foolish!
President Trump: don’t gut the budget of the White House Office of National Drug Control Policy!
Slashing spending to just $24 million from $388 million will harm nation-wide efforts to fight the deadly opioid epidemic.
ONDCP oversees essential drug programs and integrates critical government resources. Don’t be penny wise and pound foolish!
Tell the President:
DON’T dump the Drug Czar
DO save the ONDCP
Drug overdose kills more than 52,000 Americans a year—more than cancer, more than auto accidents.
A cohesive national anti-addiction policy is essential.
But the Office of Drug Control Policy (ONDCP), the part of your White House that oversees
the nation’s anti-drug efforts, is on the hit list of the Budget Office, along with PBS, Americorps, and the National Endowments.
Eliminating ONDCP will save roughly $25 million for salaries, expenses, and policy research, and denyabout $350 million to critical drug control programs.
This is penny wisdom and pound folly at its worst.
-Mitchell S. Rosenthal, MD
President
Tell the President:
DON’T dump the Drug Czar
DO save the ONDCP
Drug overdose kills more than 52,000 Americans a year—more than cancer, more than auto accidents.
A cohesive national anti-addiction policy is essential.
But the Office of Drug Control Policy (ONDCP), the part of your White House that oversees
the nation’s anti-drug efforts, is on the hit list of the Budget Office, along with PBS, Americorps, and the National Endowments.
Eliminating ONDCP will save roughly $25 million for salaries, expenses, and policy research, and denyabout $350 million to critical drug control programs.
This is penny wisdom and pound folly at its worst.
-Mitchell S. Rosenthal, MD
President